NEW ORLEANS – A single dose of a synthetic formulation of psilocybin provides rapid improvement in treatment-resistant depression, with benefits sustained for up to 12 weeks, according to results from the largest randomized controlled study of psilocybin to date. Dr Guy Goodwin “This is easily the largest study of a psychedelic drug employing […]
Read More
While men have been shown to have greater risk of COVID-19 illness compared with women, a new study shows that the lower the testosterone level in men, the higher the likelihood of severe COVID-19 disease. “During the pandemic, there has been a prevailing notion that testosterone is bad,” senior […]
Read More
In a global meta-analysis of more than 7000 patients who were hospitalized with COVID-19, individuals with overweight or obesity were more likely to need respiratory support but were not more likely to die in the hospital than individuals of normal weight. Compared to patients without diabetes, those with diabetes had higher odds […]
Read More